ArticleTobacco control2015
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
Frank J Chaloupka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled ittrialcites it